Amarin Corporation plc Stock Deutsche Boerse AG
Equities
EH3A
US0231112063
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.675 EUR | -0.74% | +12.50% | -9.40% |
Sales 2024 * | 202M 189M 278M | Sales 2025 * | 215M 201M 295M | Capitalization | 320M 299M 439M |
---|---|---|---|---|---|
Net income 2024 * | -70M -65.38M -96.11M | Net income 2025 * | -64M -59.78M -87.87M | EV / Sales 2024 * | 1.36 x |
Net cash position 2024 * | 43.92M 41.02M 60.3M | Net cash position 2025 * | 159M 148M 218M | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
-4.41
x | P/E ratio 2025 * |
-4.68
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on Amarin Corporation plc
1 day | -0.74% | ||
1 week | +12.50% | ||
Current month | -4.93% | ||
1 month | -12.34% | ||
3 months | -8.16% | ||
6 months | -5.59% | ||
Current year | -9.40% |
Managers | Title | Age | Since |
---|---|---|---|
Aaron Berg
CEO | Chief Executive Officer | 61 | 12-10-31 |
Thomas Reilly
DFI | Director of Finance/CFO | 52 | 22-06-19 |
Compliance Officer | 55 | 11-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Sterling
BRD | Director/Board Member | 45 | 23-02-27 |
Odysseas Kostas
CHM | Chairman | 49 | 23-02-27 |
Keith Horn
BRD | Director/Board Member | 66 | 23-02-27 |
Date | Price | Change |
---|---|---|
24-06-14 | 0.675 | -0.74% |
24-06-13 | 0.68 | -2.16% |
24-06-12 | 0.695 | +6.92% |
24-06-11 | 0.65 | +10.17% |
24-06-10 | 0.59 | -1.67% |
Delayed Quote Deutsche Boerse AG, June 14, 2024 at 03:50 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- AMRN Stock
- EH3A Stock